Sharena Rice describes their potential for neurotech developers. Jeremy Koff explains the factors that determine public and private companies' worth. Some Chinese firms joined a parade of new U.S. startups in the space. The epilepsy neuromodulation firm hit a bump on its quest to expand indications. Kandu Emerges from Merger as Major Stroke Rehab Player. Neurotech Luminaries Look to the Future at SynBioBeta 2025. University of Nottingham Establishes New Neurotech Center. Draining the BrainMay 2025 Issue
Organoids Offer Key Tool for Brain Implant Developers
Neurotech Startups Seek to Optimize Their Valuation
New BCI Ventures Emerge as Valuations Explode
NeuroPace Stock Takes a Hit After Clinical Trial Failure
Vendor Profile
Conference Report
Research Institution Profile
Commentary
Financial News
News Briefs
Research Highlights